Clinical trial · Observational
Specimen Banking From Patients With Lung Cancer
NCT01585675CI-TRIAL-00101975recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Neoplasms | Lung Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Diagnosis/treatment of lung cancer
- description
- Specimen Banking
Primary outcomes (1)
- measure
- Development of a comprehensive specimen banking program from patients with lung cancer for future translational research.
- timeFrame
- 6 years
- description
- No statistical analysis will be applied to the overall collection of samples. Rather, each project that utilized tissue bank resources will require an appropriate statistical plan to be submitted along with the initial tissue request.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: 1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer. 2. Oral and written informed consent Exclusion Criteria: 1\. Any individual who does not give oral and written consent for participation
References
Publications (0)
Data not yet available
No reference posted for this study.